Mentors make a difference! The Summer Scholars Program is looking for more mentors to help provide first- and second-year students from across the country opportunities to gain valuable experience in the lab.
A CRISPR-based platform identified many genes that could potentially improve T-cell therapies for cancer treatment
Bruce Donald and team are using computation strategies to figure out ways to turn those “pet quality” antibodies into “show quality” antibodies to better fight against HIV.
Our bodies have the remarkable ability to heal from these injuries, thanks to muscle stem cells.
Reliable technique should improve clinical trials, nutrition studies and historical research
Ten63 Therapeutics – a company combining generative AI and physics-based models to develop first- and best-in-class therapeutics – announced the closing of an oversubscribed $15.9 million Series A financing led by new investor Hatteras Venture Partners.
Sequencing and Genomic Technologies Director, Devjanee (Devi) Swain Lenz will be one of the invited panel speakers at the Festival of Genomics and Biodata conference
It’s an old story: Pathogen sickens humans. Humans create medicine. Pathogen evolves a way around the medicine. Humans are back to square one.
Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring on the lungs. Over time, as more scarring occurs, patients experience decreased lung function and difficulty breathing. Once diagnosed, most patients die within five years.
Raluca Gordân, PhD, and team investigated how transcription factors may affect the production of genetic mutations, or mutagenesis, by binding to the wrong sites after being exposed to ultraviolet (UV) radiation.